Valsartan Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Valsartan Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Valsartan Drug market is segmented into
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Segment by Application, the Valsartan Drug market is segmented into
Hypertension
Heart Failure
Heart Attack
Regional and Country-level Analysis
The Valsartan Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Valsartan Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Valsartan Drug Market Share Analysis
Valsartan Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Valsartan Drug business, the date to enter into the Valsartan Drug market, Valsartan Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
1 Study Coverage
1.1 Valsartan Drug Product Introduction
1.2 Market Segments
1.3 Key Valsartan Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Valsartan Drug Market Size Growth Rate by Type
1.4.2 40 mg Tablets
1.4.3 80 mg Tablets
1.4.4 160 mg Tablets
1.4.5 320 mg Tablets
1.5 Market by Application
1.5.1 Global Valsartan Drug Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Heart Failure
1.5.4 Heart Attack
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Valsartan Drug Market Size, Estimates and Forecasts
2.1.1 Global Valsartan Drug Revenue 2015-2026
2.1.2 Global Valsartan Drug Sales 2015-2026
2.2 Global Valsartan Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Valsartan Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Valsartan Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Valsartan Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Valsartan Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Valsartan Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Valsartan Drug Revenue Forecast by Region (2021-2026)
3 Global Valsartan Drug Competitor Landscape by Players
3.1 Global Top Valsartan Drug Sales by Manufacturers
3.1.1 Global Valsartan Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Valsartan Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Valsartan Drug Manufacturers by Revenue
3.2.1 Global Valsartan Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Valsartan Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Valsartan Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Valsartan Drug Revenue in 2019
3.2.5 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Valsartan Drug Price by Manufacturers
3.4 Global Valsartan Drug Manufacturing Base Distribution, Product Types
3.4.1 Valsartan Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Valsartan Drug Product Type
3.4.3 Date of International Manufacturers Enter into Valsartan Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Valsartan Drug Market Size by Type (2015-2020)
4.1.1 Global Valsartan Drug Sales by Type (2015-2020)
4.1.2 Global Valsartan Drug Revenue by Type (2015-2020)
4.1.3 Valsartan Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Valsartan Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Valsartan Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Valsartan Drug Revenue Forecast by Type (2021-2026)
4.2.3 Valsartan Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Valsartan Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Valsartan Drug Market Size by Application (2015-2020)
5.1.1 Global Valsartan Drug Sales by Application (2015-2020)
5.1.2 Global Valsartan Drug Revenue by Application (2015-2020)
5.1.3 Valsartan Drug Price by Application (2015-2020)
5.2 Valsartan Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Valsartan Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Valsartan Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Valsartan Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Valsartan Drug Market Size YoY Growth 2015-2026
6.1.1 United States Valsartan Drug Sales YoY Growth 2015-2026
6.1.2 United States Valsartan Drug Revenue YoY Growth 2015-2026
6.1.3 United States Valsartan Drug Market Share in Global Market 2015-2026
6.2 United States Valsartan Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Valsartan Drug Players by Sales (2015-2020)
6.2.2 United States Top Valsartan Drug Players by Revenue (2015-2020)
6.3 United States Valsartan Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Valsartan Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Valsartan Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Valsartan Drug Price by Type (2015-2020)
6.4 United States Valsartan Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Valsartan Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Valsartan Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Valsartan Drug Price Forecast by Type (2021-2026)
6.5 United States Valsartan Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Valsartan Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Valsartan Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Valsartan Drug Price by Application (2015-2020)
6.6 United States Valsartan Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Valsartan Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Valsartan Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Valsartan Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Valsartan Drug Market Size YoY Growth 2015-2026
7.2 North America Valsartan Drug Market Facts & Figures by Country
7.2.1 North America Valsartan Drug Sales by Country (2015-2020)
7.2.2 North America Valsartan Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Valsartan Drug Market Size YoY Growth 2015-2026
8.2 Europe Valsartan Drug Market Facts & Figures by Country
8.2.1 Europe Valsartan Drug Sales by Country
8.2.2 Europe Valsartan Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Valsartan Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Valsartan Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Valsartan Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Valsartan Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Valsartan Drug Market Size YoY Growth 2015-2026
10.2 Latin America Valsartan Drug Market Facts & Figures by Country
10.2.1 Latin America Valsartan Drug Sales by Country
10.2.2 Latin America Valsartan Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Valsartan Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Valsartan Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Valsartan Drug Sales by Country
11.2.2 Middle East and Africa Valsartan Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Valsartan Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Corporation Information
12.2.2 Sun Pharmaceutical Description and Business Overview
12.2.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sun Pharmaceutical Valsartan Drug Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Valsartan Drug Products Offered
12.3.5 Teva Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Description and Business Overview
12.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Valsartan Drug Products Offered
12.4.5 Mylan Recent Development
12.5 Alembic Pharmaceuticals
12.5.1 Alembic Pharmaceuticals Corporation Information
12.5.2 Alembic Pharmaceuticals Description and Business Overview
12.5.3 Alembic Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Alembic Pharmaceuticals Valsartan Drug Products Offered
12.5.5 Alembic Pharmaceuticals Recent Development
12.6 Lupin
12.6.1 Lupin Corporation Information
12.6.2 Lupin Description and Business Overview
12.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lupin Valsartan Drug Products Offered
12.6.5 Lupin Recent Development
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Corporation Information
12.7.2 Aurobindo Pharma Description and Business Overview
12.7.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aurobindo Pharma Valsartan Drug Products Offered
12.7.5 Aurobindo Pharma Recent Development
12.8 Macleods Pharmaceuticals
12.8.1 Macleods Pharmaceuticals Corporation Information
12.8.2 Macleods Pharmaceuticals Description and Business Overview
12.8.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Macleods Pharmaceuticals Valsartan Drug Products Offered
12.8.5 Macleods Pharmaceuticals Recent Development
12.9 HETERO
12.9.1 HETERO Corporation Information
12.9.2 HETERO Description and Business Overview
12.9.3 HETERO Sales, Revenue and Gross Margin (2015-2020)
12.9.4 HETERO Valsartan Drug Products Offered
12.9.5 HETERO Recent Development
12.10 Torrent Pharmaceuticals
12.10.1 Torrent Pharmaceuticals Corporation Information
12.10.2 Torrent Pharmaceuticals Description and Business Overview
12.10.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Torrent Pharmaceuticals Valsartan Drug Products Offered
12.10.5 Torrent Pharmaceuticals Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Valsartan Drug Products Offered
12.11.5 Novartis Recent Development
12.12 Jubilant Pharma
12.12.1 Jubilant Pharma Corporation Information
12.12.2 Jubilant Pharma Description and Business Overview
12.12.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Jubilant Pharma Products Offered
12.12.5 Jubilant Pharma Recent Development
12.13 Amneal Pharmaceuticals
12.13.1 Amneal Pharmaceuticals Corporation Information
12.13.2 Amneal Pharmaceuticals Description and Business Overview
12.13.3 Amneal Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Amneal Pharmaceuticals Products Offered
12.13.5 Amneal Pharmaceuticals Recent Development
12.14 Zhejiang Huahai Pharmaceutical
12.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.14.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
12.14.3 Zhejiang Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Zhejiang Huahai Pharmaceutical Products Offered
12.14.5 Zhejiang Huahai Pharmaceutical Recent Development
12.15 Square Pharmaceuticals
12.15.1 Square Pharmaceuticals Corporation Information
12.15.2 Square Pharmaceuticals Description and Business Overview
12.15.3 Square Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Square Pharmaceuticals Products Offered
12.15.5 Square Pharmaceuticals Recent Development
12.16 Unichem Laboratories
12.16.1 Unichem Laboratories Corporation Information
12.16.2 Unichem Laboratories Description and Business Overview
12.16.3 Unichem Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Unichem Laboratories Products Offered
12.16.5 Unichem Laboratories Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Valsartan Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Valsartan Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
*If Applicable.